Health Wire Burundi: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Burundi.

Press releases published on October 15, 2026

3 hours ago

Rethink s’associe à Joe Fresh(MC) et à la Fondation Pharmaprix pour la santé des femmes(MC)

Indeterminate GlobeNewswire

3 hours ago

Rethink Partners with Joe Fresh™ & Shoppers Foundation for Women's Health™

Indeterminate GlobeNewswire

3 hours ago

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

Indeterminate GlobeNewswire

3 hours ago

Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026

Indeterminate GlobeNewswire

3 hours ago

Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027

Indeterminate GlobeNewswire

3 hours ago

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Indeterminate GlobeNewswire

3 hours ago

Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company

Indeterminate GlobeNewswire

3 hours ago

Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire

4 hours ago

Profusa Receives ISO 13485:2016 Certificate from GMED

Indeterminate GlobeNewswire

4 hours ago

Affidea signs agreement to acquire two Alliance Medical centres in central London, accelerating its UK growth

Indeterminate GlobeNewswire

4 hours ago

Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

5 hours ago

Osivax Reports Phase 2b Results for OVX836 and Advances Combination Strategy for Next-Generation Seasonal Influenza Vaccines

Indeterminate GlobeNewswire

6 hours ago

EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe

Indeterminate GlobeNewswire

6 hours ago

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

Indeterminate GlobeNewswire

7 hours ago

Mission Therapeutics doses first Parkinson’s patient in Phase 1b study of potential disease-modifying treatment MTX325

Indeterminate GlobeNewswire

7 hours ago

iOnctura appoints Paul Sekhri as Chair of its Board of Directors

Indeterminate GlobeNewswire

7 hours ago

DaltonTx awarded grant to accelerate AI-powered tuberculosis drug discovery

Indeterminate GlobeNewswire

8 hours ago

OMass Therapeutics Announces $310 Million Series C Financing to Advance Portfolio of Small Molecule Therapeutics in Endocrinology and Immunology

Indeterminate GlobeNewswire

9 hours ago

Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

Indeterminate GlobeNewswire

9 hours ago

argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026

Indeterminate GlobeNewswire